Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 27:10:1167132.
doi: 10.3389/fcvm.2023.1167132. eCollection 2023.

Levels and clinical significance of the m6A methyltransferase METTL14 in patients with coronary heart disease

Affiliations

Levels and clinical significance of the m6A methyltransferase METTL14 in patients with coronary heart disease

Fengxia Guo et al. Front Cardiovasc Med. .

Abstract

Objective: To investigate the association of methyltransferase-like protein 14 (METTL14) expression with coronary heart disease (CHD).

Methods: Three hundred and sixteen patients who attended Henan Provincial People's Hospital between June 2019 and February 2021 with principal symptoms of pain or tightness in the chest and who underwent coronary angiography for definitive diagnosis were enrolled. The uric acid, TG, TC, LDL-C, HDL-C, apolipoprotein A1, free fatty acid, lipoprotein a, homocysteine, CRP, and SAA levels were examined. The levels of METTL14, TNF-α, MCP-1, VCAM-1, ICAM-1, and IL-6 were evaluated by ELISA.

Results: Patients with CHD had significantly higher m6A methyltransferase activity. In addition, the incidence of diabetes and hypertension, as well as the concentrations of TC, CRP, and SAA were higher in CHD patients. Patients with coronary lesion branches also had significantly increased TG, LDL-C, CRP, and SAA levels. TNF-α, MCP-1, VCAM-1, ICAM-1, and IL-6 expression was also markedly increased in the CHD group (P < 0.001) as was the expression of METTL14 (P < 0.001). The METTL14 expression levels also differed significantly in relation to the number of branches with lesions (P < 0.01) and were correlated with SAA, VCAM-1, ICAM-1, IL-6, and the Gensini score. ROC curve analyses of METTL14 in CHD indicated an AUC of 0.881 (0.679, 0.894) with a cut-off value of 342.37, a sensitivity of 77%, and a specificity of 84%. MCP-1, VCAM-1, IL-6, SAA, and METTL14 were found to independently predict CHD risk.

Conclusions: METTL14 levels were found to be positively associated with inflammatory markers and to be an independent predictor of CHD risk.

Keywords: METTL14; atherosclerosis; coronary heart disease; inflammatory markers; m6A methylation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The activity of methyltransferase.
Figure 2
Figure 2
The mRNA levels of METTL14 and FTO.

Similar articles

Cited by

References

    1. Tian Y, Deng P, Li B, Wang J, Li J, Huang Y, et al. Treatment models of cardiac rehabilitation in patients with coronary heart disease and related factors affecting patient compliance. Rev Cardiovasc Med. (2019) 20:27–33. 10.31083/j.rcm.2019.01.53 - DOI - PubMed
    1. Chen D, Liang M, Jin C, Sun Y, Xu D, Lin Y. Expression of inflammatory factors and oxidative stress markers in serum of patients with coronary heart disease and correlation with coronary artery calcium score. Exp Ther Med. (2020) 20(3):2127–33. 10.3892/etm.2020.8958 - DOI - PMC - PubMed
    1. Ndrepepa G, Holdenrieder S, Cassese S, Fusaro M, Xhepa E, Laugwitz KL, et al. A comparison of gamma-glutamyl transferase and alkaline phosphatase as prognostic markers in patients with coronary heart disease. Nutr Metab Cardiovasc Dis. (2018) 28(1):64–70. 10.1016/j.numecd.2017.09.005 - DOI - PubMed
    1. Hou P, Xue HP, Mao XE, Li YN, Wu LF, Liu YB. Inflammation markers are associated with frailty in elderly patients with coronary heart disease. Aging (Albany NY). (2018) 10(10):2636–45. 10.18632/aging.101575 - DOI - PMC - PubMed
    1. Qin Y, Li L, Luo E, Hou J, Yan G, Wang D, et al. Role of m6A RNA methylation in cardiovascular disease (review). Int J Mol Med. (2020) 46:1958–72. 10.3892/ijmm.2020.4746 - DOI - PMC - PubMed